share_log

RBC Capital Reiterates Sector Perform on Sangamo Therapeutics, Maintains $2 Price Target

Moomoo 24/7 ·  Mar 14 11:28

RBC Capital analyst Luca Issi reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Sector Perform and maintains $2 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment